Page last updated: 2024-10-26

racemetirosine and Neurilemmoma

racemetirosine has been researched along with Neurilemmoma in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Neurilemmoma: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, AR1
Watanabe, H1
Aoki, J1
Shinozaki, T1
Takagishi, K1

Other Studies

1 other study available for racemetirosine and Neurilemmoma

ArticleYear
Schwannoma of the extremities: the role of PET in preoperative planning.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:10

    Topics: Adult; Aged; alpha-Methyltyrosine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; M

2001